Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1335502
PUBLISHER: KBV Research | PRODUCT CODE: 1335502
Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Testing Type, By Technology, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 136 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CTNG) Testing Market would witness market growth of 9.2% CAGR during the forecast period (2023-2030).
Early Chlamydia and Gonorrhoeae detection becomes feasible by CT/NG testing, allowing rapid treatment and stopping the spread of diseases. As a result, communities see lower transmission rates, and individuals experience better health outcomes. The accuracy and specificity of CT/NG tests have also been improved due to developments in molecular diagnostics and genotyping techniques. These technologies make it possible to identify individual strains and patterns of medication resistance, enabling more precise treatment methods and improved infection control.
Personalized options for treatment are rendered accessible by incorporating genotyping and molecular diagnostics into CT/NG testing. It helps optimize treatment plans based on unique infection profiles, prevent antibiotic resistance, and enhance therapeutic outcomes. Additionally, the healthcare sector's integration of telemedicine and digital health platforms makes remote testing, consultations, and result distribution possible. In particular, for people in underprivileged areas, this removes geographic restrictions and improves accessibility to testing services. Professional people looking for testing services and telemedicine solutions in the market offer ease and privacy. Confidentiality is ensured with remote testing, removing obstacles and stigma connected to conventional in-person appointments.
According to a 2023 National Library of Medicine, publication named Sexually Transmitted Infections Among Key Populations in India: A Protocol for Systematic Review, between 0 to 3.9 percent of the general population in India has one of the four treatable STIs. However, subpopulations engaging in high-risk behavior are believed to have considerably greater STI prevalence than the general population. As a result, officials are taking more action to address the issues. The National AIDS Control Organization (NACO) has made STI prevention one of its primary goals in India for the past 20 years. Through its network of more than 1100 designated clinics, known as Suraksha Clinics, the NACO offers free sexual and reproductive health services based on syndromic case management through trained counselors, skilled paramedics, and experienced medical personnel. These clinics are primarily located at district-level government healthcare facilities. The market is projected to develop in this region due to the rising frequency of STDs002E.
The China market dominated the Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $227.1 million by 2030. The Japan market is registering a CAGR of 8.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on Product, the market is segmented into Assays & Kits, and Instruments & Analyzers. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Others. Based on Testing Type, the market is segmented into Lab Tests, and PoC Tests. Based on Technology, the market is segmented into Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, Immunodiagnostics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, ZeptoMetrix LLC (Antylia Scientific), Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Thermo Fisher Scientific, Inc., Bayer AG, Qiagen N.V. and Siemens AG.
Scope of the Study
Market Segments covered in the Report:
By Product
- Assays & Kits
- Instruments & Analyzers
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
By Testing Type
- Lab Tests
- PoC Tests
By Technology
- Isothermal Nucleic Acid Amplification Technology
- Polymerase Chain Reaction
- Immunodiagnostics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Abbott Laboratories
- Becton, Dickinson and Company
- ZeptoMetrix LLC (Antylia Scientific)
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- Bayer AG
- Qiagen N.V.
- Siemens AG
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Product
- 1.4.2 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by End User
- 1.4.3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Testing Type
- 1.4.4 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Technology
- 1.4.5 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter's Five Forces Analysis
Chapter 4. Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 4.1 Asia Pacific Assays & Kits Market by Country
- 4.2 Asia Pacific Instruments & Analyzers Market by Country
Chapter 5. Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 5.1 Asia Pacific Diagnostic Laboratories Market by Country
- 5.2 Asia Pacific Hospitals & Clinics Market by Country
- 5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 6.1 Asia Pacific Lab Tests Market by Country
- 6.2 Asia Pacific PoC Tests Market by Country
Chapter 7. Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 7.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country
- 7.2 Asia Pacific Polymerase Chain Reaction Market by Country
- 7.3 Asia Pacific Immunodiagnostics Market by Country
- 7.4 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country
- 8.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.1.1 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.1.2 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.1.3 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.1.4 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.2.1 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.2.2 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.2.3 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.2.4 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.3.1 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.3.2 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.3.3 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.3.4 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.4.1 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.4.2 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.4.3 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.4.4 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.5 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.5.1 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.5.2 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.5.3 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.5.4 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.6 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.6.1 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.6.2 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.6.3 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.6.4 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
- 8.7 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- 8.7.1 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product
- 8.7.2 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User
- 8.7.3 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type
- 8.7.4 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology
Chapter 9. Company Profiles
- 9.1 Abbott Laboratories
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Trials & Approvals:
- 9.1.6 SWOT Analysis
- 9.2 Becton, Dickinson, and Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 ZeptoMetrix LLC (Antylia Scientific)
- 9.3.1 Company Overview
- 9.3.2 SWOT Analysis
- 9.4 Danaher Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 F. Hoffmann-La Roche Ltd.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Trials & Approvals:
- 9.5.6 SWOT Analysis
- 9.6 Hologic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
- 9.7 Thermo Fisher Scientific, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
- 9.8 Bayer AG
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
- 9.9 Qiagen N.V.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
- 9.10. Siemens AG
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 2 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 3 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 4 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 5 Asia Pacific Assays & Kits Market by Country, 2019 - 2022, USD Million
- TABLE 6 Asia Pacific Assays & Kits Market by Country, 2023 - 2030, USD Million
- TABLE 7 Asia Pacific Instruments & Analyzers Market by Country, 2019 - 2022, USD Million
- TABLE 8 Asia Pacific Instruments & Analyzers Market by Country, 2023 - 2030, USD Million
- TABLE 9 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 10 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 11 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
- TABLE 12 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
- TABLE 13 Asia Pacific Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 14 Asia Pacific Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 15 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 16 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 17 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 18 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 19 Asia Pacific Lab Tests Market by Country, 2019 - 2022, USD Million
- TABLE 20 Asia Pacific Lab Tests Market by Country, 2023 - 2030, USD Million
- TABLE 21 Asia Pacific PoC Tests Market by Country, 2019 - 2022, USD Million
- TABLE 22 Asia Pacific PoC Tests Market by Country, 2023 - 2030, USD Million
- TABLE 23 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 24 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 25 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2019 - 2022, USD Million
- TABLE 26 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Country, 2023 - 2030, USD Million
- TABLE 27 Asia Pacific Polymerase Chain Reaction Market by Country, 2019 - 2022, USD Million
- TABLE 28 Asia Pacific Polymerase Chain Reaction Market by Country, 2023 - 2030, USD Million
- TABLE 29 Asia Pacific Immunodiagnostics Market by Country, 2019 - 2022, USD Million
- TABLE 30 Asia Pacific Immunodiagnostics Market by Country, 2023 - 2030, USD Million
- TABLE 31 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 32 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 33 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2022, USD Million
- TABLE 34 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2023 - 2030, USD Million
- TABLE 35 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 36 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 37 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 38 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 39 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 40 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 41 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 42 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 43 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 44 China Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 45 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 46 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 47 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 48 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 49 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 50 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 51 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 52 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 53 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 54 Japan Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 55 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 56 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 57 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 58 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 59 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 60 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 61 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 62 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 63 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 64 India Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 65 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 66 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 67 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 68 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 69 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 70 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 71 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 72 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 73 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 74 South Korea Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 75 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 76 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 77 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 78 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 79 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 80 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 81 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 82 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 83 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 84 Singapore Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 85 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 86 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 87 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 88 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 89 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 90 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 91 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 92 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 93 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 94 Malaysia Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 95 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2022, USD Million
- TABLE 96 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2023 - 2030, USD Million
- TABLE 97 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2022, USD Million
- TABLE 98 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2023 - 2030, USD Million
- TABLE 99 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2022, USD Million
- TABLE 100 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2023 - 2030, USD Million
- TABLE 101 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2022, USD Million
- TABLE 102 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2023 - 2030, USD Million
- TABLE 103 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2022, USD Million
- TABLE 104 Rest of Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2023 - 2030, USD Million
- TABLE 105 Key Information - Abbott Laboratories
- TABLE 106 Key information - Becton, Dickinson and Company
- TABLE 107 Key Information - ZeptoMetrix LLC
- TABLE 108 Key Information - Danaher Corporation
- TABLE 109 Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 110 Key Information - Hologic, Inc.
- TABLE 111 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Qiagen N.V.
- TABLE 114 Key Information - Siemens AG
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market, 2019 - 2030, USD Million
- FIG 3 Key Impacting Factors chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) testing market
- FIG 4 Porter's Five Forces Analysis - Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market
- FIG 5 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2022
- FIG 6 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Product, 2030
- FIG 7 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Product, 2019 - 2030, USD Million
- FIG 8 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2022
- FIG 9 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by End User, 2030
- FIG 10 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by End User, 2019 - 2030, USD Million
- FIG 11 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2022
- FIG 12 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Testing Type, 2030
- FIG 13 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Testing Type, 2019 - 2030, USD Million
- FIG 14 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2022
- FIG 15 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Technology, 2030
- FIG 16 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Technology, 2019 - 2030, USD Million
- FIG 17 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2022
- FIG 18 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market share by Country, 2030
- FIG 19 Asia Pacific Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) Testing Market by Country, 2019 - 2030, USD Million
- FIG 20 SWOT Analysis: Abbott Laboratories
- FIG 21 SWOT Analysis: Becton, Dickinson and company
- FIG 22 SWOT Analysis: Becton, Dickinson and company
- FIG 23 SWOT Analysis: Danaher Corporation
- FIG 24 Swot Analysis: F. Hoffmann-La Roche Ltd.
- FIG 25 Swot Analysis: Hologic, Inc.
- FIG 26 Swot Analysis: Thermo Fisher Scientific, Inc.
- FIG 27 Swot Analysis: Bayer AG
- FIG 28 Swot Analysis: Qiagen N.V.
- FIG 29 SWOT Analysis: Siemens AG
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.